Henry Ernest Holets, MD | |
1290 Chess St, Monongahela, PA 15063-2716 | |
(724) 258-7500 | |
(724) 258-3618 |
Full Name | Henry Ernest Holets |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 49 Years |
Location | 1290 Chess St, Monongahela, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083638043 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 017917E (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Tcm Home Health | Washington, PA | Home health agency |
Ospta At Home | Belle vernon, PA | Home health agency |
Amedisys Home Health Of Pa | Uniontown, PA | Home health agency |
Monongahela Valley Hospital | Monongahela, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Henry E Holets Md Llc | 8820089246 | 2 |
News Archive
Cardiovascular disease, including heart disease and stroke, is the leading cause of death in the United States. To help combat this epidemic, studies throughout the United States pinpoint dietary guidelines to reduce risk including a recent release from the American Heart Association which stated that hypertensive patients should avoid alcoholic beverages.
The University of Colorado and Viral Genetics Inc., recently executed an exclusive license agreement that expands on its previous agreement allowing Viral Genetics to develop treatments for autoimmune diseases, graft rejection, HIV, and cancer based on the work of M. Karen Newell, Ph.D., a professor of biology at the University of Colorado at Colorado Springs.
Endo Pharmaceuticals (Nasdaq: ENDP) today announced the availability of VALSTAR(TM) (valrubicin) for the treatment of a distinct form of bladder cancer. VALSTAR is the only FDA-approved intravesical therapy for patients with Bacille Calmette-Guerin (BCG)-refractory carcinoma in situ (CIS) of the urinary bladder for whom immediate removal of the bladder would be associated with unacceptable medical risks.
A new study published in the journal Nature Communications in February 2020 shows that secretions from stem cells in the lung can be utilized to nebulize injured lungs due to several types of lung fibrosis in rats and mice. This could well result in the development of less invasive and more effective therapies for lung fibrosis.
With renewed calls for bipartisan collaboration supporting high-quality, person-centered, and affordable health coverage for us all as we age, the American Geriatrics Society this week reached out to leaders from the U.S. Senate and House of Representatives to reinforce core priorities "that matter to the millions of older adults and caregivers who we serve in the clinic-and who you serve in Congress."
› Verified 8 days ago
Entity Name | Henry E Holets Md Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881772804 PECOS PAC ID: 8820089246 Enrollment ID: O20110103000842 |
News Archive
Cardiovascular disease, including heart disease and stroke, is the leading cause of death in the United States. To help combat this epidemic, studies throughout the United States pinpoint dietary guidelines to reduce risk including a recent release from the American Heart Association which stated that hypertensive patients should avoid alcoholic beverages.
The University of Colorado and Viral Genetics Inc., recently executed an exclusive license agreement that expands on its previous agreement allowing Viral Genetics to develop treatments for autoimmune diseases, graft rejection, HIV, and cancer based on the work of M. Karen Newell, Ph.D., a professor of biology at the University of Colorado at Colorado Springs.
Endo Pharmaceuticals (Nasdaq: ENDP) today announced the availability of VALSTAR(TM) (valrubicin) for the treatment of a distinct form of bladder cancer. VALSTAR is the only FDA-approved intravesical therapy for patients with Bacille Calmette-Guerin (BCG)-refractory carcinoma in situ (CIS) of the urinary bladder for whom immediate removal of the bladder would be associated with unacceptable medical risks.
A new study published in the journal Nature Communications in February 2020 shows that secretions from stem cells in the lung can be utilized to nebulize injured lungs due to several types of lung fibrosis in rats and mice. This could well result in the development of less invasive and more effective therapies for lung fibrosis.
With renewed calls for bipartisan collaboration supporting high-quality, person-centered, and affordable health coverage for us all as we age, the American Geriatrics Society this week reached out to leaders from the U.S. Senate and House of Representatives to reinforce core priorities "that matter to the millions of older adults and caregivers who we serve in the clinic-and who you serve in Congress."
› Verified 8 days ago
Entity Name | Diana Hricova Do Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649959479 PECOS PAC ID: 7113375189 Enrollment ID: O20231130004062 |
News Archive
Cardiovascular disease, including heart disease and stroke, is the leading cause of death in the United States. To help combat this epidemic, studies throughout the United States pinpoint dietary guidelines to reduce risk including a recent release from the American Heart Association which stated that hypertensive patients should avoid alcoholic beverages.
The University of Colorado and Viral Genetics Inc., recently executed an exclusive license agreement that expands on its previous agreement allowing Viral Genetics to develop treatments for autoimmune diseases, graft rejection, HIV, and cancer based on the work of M. Karen Newell, Ph.D., a professor of biology at the University of Colorado at Colorado Springs.
Endo Pharmaceuticals (Nasdaq: ENDP) today announced the availability of VALSTAR(TM) (valrubicin) for the treatment of a distinct form of bladder cancer. VALSTAR is the only FDA-approved intravesical therapy for patients with Bacille Calmette-Guerin (BCG)-refractory carcinoma in situ (CIS) of the urinary bladder for whom immediate removal of the bladder would be associated with unacceptable medical risks.
A new study published in the journal Nature Communications in February 2020 shows that secretions from stem cells in the lung can be utilized to nebulize injured lungs due to several types of lung fibrosis in rats and mice. This could well result in the development of less invasive and more effective therapies for lung fibrosis.
With renewed calls for bipartisan collaboration supporting high-quality, person-centered, and affordable health coverage for us all as we age, the American Geriatrics Society this week reached out to leaders from the U.S. Senate and House of Representatives to reinforce core priorities "that matter to the millions of older adults and caregivers who we serve in the clinic-and who you serve in Congress."
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Henry Ernest Holets, MD 1290 Chess St, 2nd Floor, Monongahela, PA 15063-2716 Ph: (724) 258-7500 | Henry Ernest Holets, MD 1290 Chess St, Monongahela, PA 15063-2716 Ph: (724) 258-7500 |
News Archive
Cardiovascular disease, including heart disease and stroke, is the leading cause of death in the United States. To help combat this epidemic, studies throughout the United States pinpoint dietary guidelines to reduce risk including a recent release from the American Heart Association which stated that hypertensive patients should avoid alcoholic beverages.
The University of Colorado and Viral Genetics Inc., recently executed an exclusive license agreement that expands on its previous agreement allowing Viral Genetics to develop treatments for autoimmune diseases, graft rejection, HIV, and cancer based on the work of M. Karen Newell, Ph.D., a professor of biology at the University of Colorado at Colorado Springs.
Endo Pharmaceuticals (Nasdaq: ENDP) today announced the availability of VALSTAR(TM) (valrubicin) for the treatment of a distinct form of bladder cancer. VALSTAR is the only FDA-approved intravesical therapy for patients with Bacille Calmette-Guerin (BCG)-refractory carcinoma in situ (CIS) of the urinary bladder for whom immediate removal of the bladder would be associated with unacceptable medical risks.
A new study published in the journal Nature Communications in February 2020 shows that secretions from stem cells in the lung can be utilized to nebulize injured lungs due to several types of lung fibrosis in rats and mice. This could well result in the development of less invasive and more effective therapies for lung fibrosis.
With renewed calls for bipartisan collaboration supporting high-quality, person-centered, and affordable health coverage for us all as we age, the American Geriatrics Society this week reached out to leaders from the U.S. Senate and House of Representatives to reinforce core priorities "that matter to the millions of older adults and caregivers who we serve in the clinic-and who you serve in Congress."
› Verified 8 days ago
Dr. Anthony Zinobile, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1163 Country Club Rd, Monongahela, PA 15063 Phone: 724-258-1001 | |
Charles Lomago Jr., DMD Family Medicine Medicare: Medicare Enrolled Practice Location: 447 West Main Street, Monongahela, PA 15063 Phone: 724-258-2220 | |
John Alan Holets, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 447 W Main St, Monongahela, PA 15063 Phone: 724-258-2070 Fax: 724-258-3582 | |
Mrs. Christa Marie Malinak, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Stoops Dr Ste 320, Monongahela, PA 15063 Phone: 724-565-5393 Fax: 724-565-5393 | |
John Charles Eisley, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 447 W Main St, Monongahela, PA 15063 Phone: 724-258-2070 Fax: 724-258-3582 |